SCHEMBL4459490

SCHEMBL4459490

O=C(O)Nc1nnc(-c2ccc(Br)cc2)s1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.62
HDAC2 Q92769 4/20 0.62
BLM P54132 1/20 0.59
HPN P05981 1/20 0.58
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA4 P22748 1/20 0.56
CA5A P35218 1/20 0.56
CA5B Q9Y2D0 1/20 0.56
CSNK2A2 P19784 6/20 0.55
CSNK2A1 P68400 6/20 0.55
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
MAPT P10636 4/20 0.51
HDAC3 O15379 2/20 0.51
HDAC4 P56524 2/20 0.51
HDAC7 Q8WUI4 2/20 0.51
HDAC10 Q969S8 2/20 0.51
HDAC11 Q96DB2 2/20 0.51
HDAC8 Q9BY41 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20522351 0.85 CSNK2A2 (0.70) HDAC1HDAC2BLMHPNCA1
SCHEMBL3828303 0.84 NPC1 (0.71) CA1CA2CA4CA5ACA5B
SCHEMBL7930408 0.81 HDAC1 (0.67) HDAC1HDAC2BLMHPNCA1
SCHEMBL11386451 0.80 ALDH1A1 (0.58) HDAC1HDAC2BLMHPNCSNK2A2
SCHEMBL4468253 0.78 CSNK2A2 (0.77) HDAC1HDAC2BLMCSNK2A2CSNK2A1
SCHEMBL20522295 0.78 CSNK2A2 (0.60) HDAC1HDAC2BLMHPNCA1
SCHEMBL12986710 0.77 HDAC1 (0.77) HDAC1HDAC2HPNHDAC3HDAC4
SCHEMBL11392290 0.77 RXFP1 (0.65) HDAC1HDAC2BLMHPNCSNK2A2
SCHEMBL18762150 0.76 BLM (0.70) HDAC1HDAC2BLMCSNK2A2CSNK2A1
SCHEMBL22532425 0.76 CSNK2A2 (0.62) HDAC1HDAC2CSNK2A2CSNK2A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO disclosed